Jens Juul Holst

Jens Juul Holst (born 1 August 1945) is a Danish physician and physiologist. He is known for discovering and describing the hormone glucagon-like peptide-1 (GLP-1), a hormone in the gut that plays an important role in the onset and development of Type 2 diabetes.[1]

Jens Juul Holst
Born (1945-08-01) 1 August 1945
Copenhagen, Denmark
Alma materUniversity of Copenhagen
Scientific career
Fields
InstitutionsUniversity of Copenhagen

In 2020, he was awarded the Warren Alpert Foundation Prize along Daniel J. Drucker and Joel F. Habener.[2]

In 2021, he was awarded the Canada Gairdner International Award along Daniel J. Drucker, Joel F. Habener, and Mary-Claire King.[3] He was also awarded the Banting Medal by the American Diabetes Association (ADA).[4]

In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research along Daniel J. Drucker, Jeffrey M. Friedman, Joel F. Habener, and Svetlana Mojsov.[5] and also in 2024 he received the Tang Prize in the category of "Biopharmaceutical Science".[6]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.